Peripheral T-cell lymphoma (PTCL)
- Treat according to specific T-cell lymphoma subtype
- Combination chemotherapy remains a common first-line backbone
- Brentuximab-containing therapy for CD30-positive disease
- Consolidative transplant considered in selected patients
- Relapsed disease uses targeted/epigenetic agents or transplant
- Expert pathology review is important
Use at a glance
- Treat according to specific T-cell lymphoma subtype
Treatment options
- Combination chemotherapy remains a common first-line backbone
Other treatment options
- Brentuximab-containing therapy for CD30-positive disease
- Expert pathology review is important
Escalation / refractory disease
- Consolidative transplant considered in selected patients
- Relapsed disease uses targeted/epigenetic agents or transplant
Self-check
- What should be treated in Peripheral T-cell lymphoma (PTCL)?
according to specific T-cell lymphoma subtype.
- What is used for CD30-positive in Peripheral T-cell lymphoma (PTCL)?
Brentuximab-containing therapy.
Drugs used for this (1)
All clinical uses · Open the interactive console ↗
